Biorelate raised €7.5M in a Series A round in Nov 2022. The company is based in Oldham, UK. Investors in the round: Manchester Tech Trust angels, Maven Capital Partners, Triple Point Ventures and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
